Literature DB >> 17653633

Aggressive surgical approach for stage IV gallbladder carcinoma based on Japanese Society of Biliary Surgery classification.

Hiroaki Shimizu1, Fumio Kimura, Hiroyuki Yoshidome, Masayuki Ohtsuka, Atsushi Kato, Hideaki Yoshitomi, Satoshi Nozawa, Katunori Furukawa, Noboru Mitsuhashi, Dan Takeuchi, Kosuke Suda, Isaku Yoshioka, Masaru Miyazaki.   

Abstract

BACKGROUND/
PURPOSE: The role of aggressive surgery for stage IV gallbladder carcinoma remains controversial. Survival and prognostic factors were analyzed in patients with stage IV disease, based on the Japanese Society of Biliary Surgery (JSBS) classification, to identify the group of patients who could benefit from radical surgery.
METHODS: A retrospective analysis was done of 79 patients with JSBS stage IV gallbladder carcinoma who had undergone surgical resection with curative intent at our institution. The standard procedures were anatomical S4a + S5 subsegmentectomy (n = 29) with extrahepatic bile duct resection and extended lymphadectomy, but when right Glisson's sheath and/or the hepatic hilum were involved, right extended hepatectomy (n = 34) or right trisegmentectomy (n = 3) was selected. To achieve a tumor-free margin combined pancreaticoduodenectomy was performed in 12 patients, and major vascular resection in 17 patients.
RESULTS: In the patients with stage IV gallbladder carcinoma, the curative resection rate was 65.8% and the hospital mortality rate was 11.4%. The postoperative 5-year survival rate following curative resection was 13.7%. Univariate analysis indicated that curability, hepatoduodenal ligament invasion, nodal involvement, and vascular resection were significant prognostic factors. Neither hepatic invasion nor liver metastasis was a significant factor.
CONCLUSIONS: Aggressive surgical resection should be considered even in stage IV patients when hepatoduodenal ligament invasion and nodal involvement are absent or limited. Acceptable survival may be expected among such patients only when curative resection is achieved.

Entities:  

Mesh:

Year:  2007        PMID: 17653633     DOI: 10.1007/s00534-006-1188-z

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  25 in total

1.  Surgery for gallbladder cancer: The need to generate greater evidence.

Authors:  Shailesh V Shrikhande; Savio G Barreto
Journal:  World J Gastrointest Surg       Date:  2009-11-30

2.  Invasion of the hepatic artery is a crucial predictor of poor outcomes in gallbladder carcinoma.

Authors:  Akihiko Kobayashi; Tatsuya Oda; Kiyoshi Fukunaga; Ryoko Sasaki; Nobuhiro Ohkohchi
Journal:  World J Surg       Date:  2012-03       Impact factor: 3.352

3.  Prognostic factors of patients with advanced gallbladder carcinoma following aggressive surgical resection.

Authors:  Yoshiaki Murakami; Kenichiro Uemura; Takeshi Sudo; Yasushi Hashimoto; Akira Nakashima; Naru Kondo; Ryutaro Sakabe; Hironori Kobayashi; Taijiro Sueda
Journal:  J Gastrointest Surg       Date:  2011-03-10       Impact factor: 3.452

4.  A prospective analysis of the preoperative assessment of duodenal involvement in gallbladder cancer.

Authors:  Raja Kalayarasan; Amit Javed; Amarender S Puri; Sunil K Puri; Puja Sakhuja; Anil K Agarwal
Journal:  HPB (Oxford)       Date:  2012-08-01       Impact factor: 3.647

5.  Changing Odds of Survival Over Time among Patients Undergoing Surgical Resection of Gallbladder Carcinoma.

Authors:  Stefan Buettner; Georgios Antonios Margonis; Yuhree Kim; Faiz Gani; Cecilia G Ethun; George A Poultsides; Thuy Tran; Kamran Idrees; Chelsea A Isom; Ryan C Fields; Bradley Krasnick; Sharon M Weber; Ahmed Salem; Robert C G Martin; Charles R Scoggins; Perry Shen; Harveshp D Mogal; Carl Schmidt; Eliza Beal; Ioannis Hatzaras; Rivfka Shenoy; Shishir K Maithel; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2016-08-05       Impact factor: 5.344

Review 6.  Gallbladder cancer, treatment failure and relapses: the peritoneum in gallbladder cancer.

Authors:  Charlotte Maplanka
Journal:  J Gastrointest Cancer       Date:  2014-09

7.  Surgical strategy for T2 and T3 gallbladder cancer: is extrahepatic bile duct resection always necessary?

Authors:  Sae Byeol Choi; Hyung Joon Han; Wan Bae Kim; Tae Jin Song; Sung Ock Suh; Sang Yong Choi
Journal:  Langenbecks Arch Surg       Date:  2013-09-21       Impact factor: 3.445

8.  Expression of hypoxia-inducible factor-1 alpha (HIF-1alpha) in patients with the gallbladder carcinoma.

Authors:  Erdenebulgan Batmunkh; Mitsuo Shimada; Yuji Morine; Satoru Imura; Hirofumi Kanemura; Yusuke Arakawa; Jun Hanaoka; Mami Kanamoto; Koji Sugimoto; Masaaki Nishi
Journal:  Int J Clin Oncol       Date:  2010-02       Impact factor: 3.402

9.  Assessing the impact of common bile duct resection in the surgical management of gallbladder cancer.

Authors:  Faiz Gani; Stefan Buettner; Georgios A Margonis; Cecilia G Ethun; George Poultsides; Thuy Tran; Kamran Idrees; Chelsea A Isom; Ryan C Fields; Bradley Krasnick; Sharon M Weber; Ahmed Salem; Robert C G Martin; Charles Scoggins; Perry Shen; Harveshp D Mogal; Carl Schmidt; Eliza Beal; Ioannis Hatzaras; Rivfka Shenoy; Shishir K Maithel; Timothy M Pawlik
Journal:  J Surg Oncol       Date:  2016-05-20       Impact factor: 3.454

10.  Incidental gallbladder cancer during laparoscopic cholecystectomy: managing an unexpected finding.

Authors:  Andrea Cavallaro; Gaetano Piccolo; Vincenzo Panebianco; Emanuele Lo Menzo; Massimiliano Berretta; Antonio Zanghì; Maria Di Vita; Alessandro Cappellani
Journal:  World J Gastroenterol       Date:  2012-08-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.